Literature DB >> 2413693

Vitamin D metabolites in generalized scleroderma. Evidence of a normal cutaneous and intestinal supply with vitamin D.

J Serup, H Hagdrup.   

Abstract

Vitamin D metabolites in serum were analysed in 20 patients with generalized scleroderma. The concentration of 1,25-dihydroxyvitamin D was normal, however, significantly lower concentrations (p less than 0.05) were found in 7 patients with cutaneous calcinosis in comparison with 13 patients with no calcinosis. Concentrations of 25-hydroxyvitamin D, 24-25-dihydroxyvitamin D, and vitamin D-binding protein (Gc globulin) were all within the normal range. The 24,25-dihydroxy-vitamin D level correlated with the duration of disease (r = 0.4453, p less than 0.05), and 25-hydroxyvitamin D tended to correlate (r = 0.3016, NS). The study strongly indicates that cutaneous synthesis, intestinal absorption and hepatic hydroxylation of vitamin D are not deficient in scleroderma. A relative but specific decrease in the renal hydroxylation to 1,25-dihydroxyvitamin D, i.e. the active hormone, as the disease progresses and calcinosis occurs, is suspected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413693

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

1.  Dietary intake and nutritional status in patients with systemic sclerosis.

Authors:  A C Lundberg; A Akesson; B Akesson
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

Review 2.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

Review 3.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

4.  Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature.

Authors:  Dilia Giuggioli; M Colaci; G Cassone; P Fallahi; F Lumetti; A Spinella; F Campomori; A Manfredi; C U Manzini; A Antonelli; C Ferri
Journal:  Clin Rheumatol       Date:  2017-01-09       Impact factor: 2.980

Review 5.  Vitamin D treatment for connective tissue diseases: hope beyond the hype?

Authors:  John A Reynolds; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2016-05-13       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.